NCT02320604View on ClinicalTrials.gov

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

November 3, 2018

Study Completion Date

November 3, 2018

Conditions

Morbid Obesity

Interventions

DRUG

Administration of study drug

i.v. administration of Ambisome in two different dossages

Trial Locations (2)

Unknown

Radboud University Medical Center, Nijmegen

St. Antonius hospital, Nieuwegein

All Listed Sponsors

lead

Radboud University Medical Center

OTHER

NCT02320604 - Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN) | Biotech Hunter | Biotech Hunter